Heartflow, Inc. (NASDAQ: HTFL) Chief Executive Officer John C.M. Farquhar disposed of 9,725 shares of common stock at a price of $25.00 per share on March 18, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The sale generated $243,125 in proceeds and was executed under a pre-arranged Rule 10b5-1 trading plan that the executive adopted on September 12, 2025.
Following the trade, Farquhar retains direct ownership of 571,725 shares of the company. The Form 4 filing indicates the transaction was signed by Nga Van, acting by power of attorney, on March 20, 2026.
The stock has experienced notable short-term momentum, rising 27% over the past week and trading at $26.03 at the time of the filing. InvestingPro commentary included with the regulatory information cautions that the shares appear overvalued at current levels. An InvestingPro tip further notes that Heartflow is not expected to be profitable this year, an observation that appears among other insights available in a broader Pro Research Report.
Quarterly results and analyst response
Separately from the insider transaction, Heartflow announced fourth-quarter 2025 financial results that outperformed expectations. The company reported revenue of $49.1 million, topping the consensus estimate of $46.6 million and representing a 40% increase year over year. Earnings per share were reported at negative $0.12, which beat the forecast of negative $0.15.
Analysts reacted to the quarterly report and the company’s initial 2026 guidance. Piper Sandler reiterated an Overweight rating on Heartflow and kept a price target of $38.00. Canaccord responded by raising its price target from $40 to $43 while maintaining a Buy rating. Both firms cited the company’s strong fourth-quarter performance and early guidance for 2026 in explaining their stances.
Context and implications
The disclosed sale was placed on record through the standard SEC Form 4 mechanism and executed under a pre-existing 10b5-1 plan, indicating the trade followed predetermined parameters rather than ad hoc timing. The contemporaneous rise in the share price and the InvestingPro valuation note are recorded details accompanying the regulatory filing and analyst commentary.
Key points
- CEO John C.M. Farquhar sold 9,725 shares at $25.00 on March 18, 2026 for $243,125 under a 10b5-1 plan.
- After the sale, Farquhar directly owns 571,725 Heartflow shares; the Form 4 was signed by Nga Van on March 20, 2026.
- Heartflow reported Q4 2025 revenue of $49.1 million and EPS of -$0.12, prompting Piper Sandler and Canaccord to maintain or raise their positive ratings and price targets.
Risks and uncertainties
- Valuation concern - InvestingPro indicates the shares appear overvalued at current trading levels, which could affect investor appetite.
- Profitability outlook - An InvestingPro tip notes Heartflow is not expected to be profitable this year, a factor relevant to equity valuation and investor expectations.
- Market momentum - The stock's 27% rise over the prior week may introduce short-term volatility despite favorable analyst commentary.
These items reflect the information disclosed in the company filing and public analyst notes. No additional events, causal explanations, or forecasts beyond those reported in the filing and research notes are asserted here.